WO2005064007A3 - MOYENS DE CRIBLAGE POUR L’IDENTIFICATION DE REGULATEURS DE L’ACTIVITE GTPase - Google Patents

MOYENS DE CRIBLAGE POUR L’IDENTIFICATION DE REGULATEURS DE L’ACTIVITE GTPase Download PDF

Info

Publication number
WO2005064007A3
WO2005064007A3 PCT/FR2004/002840 FR2004002840W WO2005064007A3 WO 2005064007 A3 WO2005064007 A3 WO 2005064007A3 FR 2004002840 W FR2004002840 W FR 2004002840W WO 2005064007 A3 WO2005064007 A3 WO 2005064007A3
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
screening
expressing
controllers
hybrid protein
Prior art date
Application number
PCT/FR2004/002840
Other languages
English (en)
Other versions
WO2005064007A2 (fr
Inventor
Anne Blangy
Philippe Fort
Audrey Salomon
Original Assignee
Centre Nat Rech Scient
Anne Blangy
Philippe Fort
Audrey Salomon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Anne Blangy, Philippe Fort, Audrey Salomon filed Critical Centre Nat Rech Scient
Publication of WO2005064007A2 publication Critical patent/WO2005064007A2/fr
Publication of WO2005064007A3 publication Critical patent/WO2005064007A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente demande de brevet est relative à des moyens pour l’analyse de la régulation des voies d’activation des GTPases, qui sont spécialement adaptés à l’identification par criblage d’un composé capable d’exercer une activité inhibitrice sur une voie d’activation de GTPase. Ces moyens comprennent une levure à forte perméabilité membranaire (erg6) et au moins un système pour l’expression d’au moins une protéine hybride de type double hybride par cette levure, ou bien une levure et au moins un système pour l’expression d’au moins une protéine hybride de type double hybride intégré dans le génome de la levure, ou destiné à l’être. Ces moyens sont entièrement automatisables, et permettent la production de composés susceptibles de permettre de lutter contre une cellule tumorale, et/ou contre l’hypertension, et/ou contre une infection, contre le développement d’une maladie génétique.
PCT/FR2004/002840 2003-11-28 2004-11-04 MOYENS DE CRIBLAGE POUR L’IDENTIFICATION DE REGULATEURS DE L’ACTIVITE GTPase WO2005064007A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0314032A FR2862983B1 (fr) 2003-11-28 2003-11-28 Moyens de criblage pour l'identification de regulateurs de l'activite gtpase
FR0314032 2003-11-28

Publications (2)

Publication Number Publication Date
WO2005064007A2 WO2005064007A2 (fr) 2005-07-14
WO2005064007A3 true WO2005064007A3 (fr) 2005-09-09

Family

ID=34566251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/002840 WO2005064007A2 (fr) 2003-11-28 2004-11-04 MOYENS DE CRIBLAGE POUR L’IDENTIFICATION DE REGULATEURS DE L’ACTIVITE GTPase

Country Status (2)

Country Link
FR (1) FR2862983B1 (fr)
WO (1) WO2005064007A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2157433A1 (fr) 2008-08-18 2010-02-24 Centre National De La Recherche Scientifique (Cnrs) Nouveau procédé pour identifier des composés utiles pour le traitement et/ou la prévention de maladies liées à la perte osseuse
US8940798B2 (en) 2011-11-04 2015-01-27 Centre National De La Recherche Scientifique (Cnrs) Compounds useful for treating and/or preventing disease-associated bone loss

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034137A2 (fr) * 1996-03-12 1997-09-18 Smithkline Beecham Corporation Procede d'identification de composes pharmaceutiquement actifs
WO1999052941A2 (fr) * 1998-04-09 1999-10-21 Medical Research Council Domaines polypeptidiques capables de se fixer aux proteines rho et leur utilisation dans des analyses
US20020173622A1 (en) * 2001-03-14 2002-11-21 Wettstein Daniel Albert Tsg101-GAGp6 interaction and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034137A2 (fr) * 1996-03-12 1997-09-18 Smithkline Beecham Corporation Procede d'identification de composes pharmaceutiquement actifs
WO1999052941A2 (fr) * 1998-04-09 1999-10-21 Medical Research Council Domaines polypeptidiques capables de se fixer aux proteines rho et leur utilisation dans des analyses
US20020173622A1 (en) * 2001-03-14 2002-11-21 Wettstein Daniel Albert Tsg101-GAGp6 interaction and use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DE TOLEDO^A M ET AL: "The yeast exchange assay, a new complementary method to screen for Dbl-like protein specificity: identification of a novel RhoA exchange factor", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 480, no. 2-3, 1 September 2000 (2000-09-01), pages 287 - 292, XP004337539, ISSN: 0014-5793 *
FIELDS S ET AL: "A NOVEL GENETIC SYSTEM TO DETECT PROTEIN-PROTEIN INTERACTIONS", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 340, no. 6230, 20 July 1989 (1989-07-20), pages 245 - 246, XP000103144, ISSN: 0028-0836 *
GABER R F ET AL: "The Yeast Gene ERG6 is Required for Nomal Membrane Function but is not essential for Biosynthesis of the Cell-Cycle-Sparking Sterol", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 9, no. 8, 1989, pages 3447 - 3456, XP002173913, ISSN: 0270-7306 *

Also Published As

Publication number Publication date
FR2862983A1 (fr) 2005-06-03
WO2005064007A2 (fr) 2005-07-14
FR2862983B1 (fr) 2006-04-07

Similar Documents

Publication Publication Date Title
WO2005007814A3 (fr) Mappage genomique d'elements d'adn fonctionnels et de proteines cellulaires
AU2002255478A1 (en) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
WO2004111603A3 (fr) Marqueurs de l'expression genetique permettant de predire la reponse une chimiotherapie
EP1472984B8 (fr) Système de contrôle pour effectuer une opération électrochirurgicale
EP2581449A3 (fr) Nouveaux genes lies a glutaminyl cyclase
WO2007137114A8 (fr) Minichromosomes de plantes artificielles
AU2003217552A1 (en) Selective extraction of dna from groups of cells
WO2004094475A3 (fr) Anticorps se fixant au facteur tissulaire et leurs utilisations
WO2007056435A3 (fr) Maladies mediees par la dynamine et procedes et produits associes
WO2006132739A3 (fr) Nouveaux composes chimiques
WO2005067648A3 (fr) Profilage spatial multiplex d'expression genique
EP1581646A3 (fr) Extraction d'adn contenu dans des echantillons biologiques
WO2006047728A3 (fr) Genes bmp et proteines de fusion
WO2006046134A3 (fr) Procede d'essai par le biais de peptides sensibles a la conformation
WO2007120955A3 (fr) Gènes agissant sur les performances de la mémoire humaine
WO2005064007A3 (fr) MOYENS DE CRIBLAGE POUR L’IDENTIFICATION DE REGULATEURS DE L’ACTIVITE GTPase
AU2003284127A1 (en) Nucleic acid supported protein complementation
WO2002092858A3 (fr) Technique de recherche de maladie
WO2004051269A3 (fr) Proteine de replication
AU2003290609A1 (en) Control system for catalytic processes
WO2006127458A3 (fr) Nouveaux composes chimiques
WO2003093434A3 (fr) Genome nanoarchaeum, polypeptides nanoarchaeum et acides nucleiques les codant et leurs procedes de fabrication et d'utilisation
WO2001096873A3 (fr) Procede d'identification de proteines a apoptose modifiee
WO2006065971A3 (fr) Compositions et methodes concernant l'amplification et la detection de polynucleotides
WO2008140637A3 (fr) Protéines et peptides de staphylococcus aureus secrétées en vue d'une utilisation dans l'inhibition de l'activation du système du complément

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase